Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
Published January 2, 2013 · Recall initiated: July 25, 2012
Summary
FDA records drug Class II recall D-103-2013, published January 2, 2013 and initiated July 25, 2012. Recalling firm: Lloyd Inc. of Iowa; Status: Terminated; Reported quantity: 16,548/100-tablet bottles; Lot: Lot 1094098, exp. date 9/2012. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent; 9-month stability interval
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Lloyd Inc. of Iowa
- Distributor
- Distribution was nationwide and to Puerto Rico. There was no foreign, military, or government distribution.
- Lot
- Lot 1094098, exp. date 9/2012
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALloyd Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging,May 29, 2013
- FDALloyd Thyro-Tab 0.150 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging,May 29, 2013
- FDALevothroid (levothyroxine sodium tablets, USP), 137 mcg, RX only, 100 tablets per bottle, Manufactured forMay 29, 2013
- FDALevothroid (levothyroxine sodium tablets, USP), 112 mcg, RX only, 100 tablets per bottle, Manufactured forMay 29, 2013
- FDAThyro-Tab 0.075 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label isJanuary 2, 2013
- FDALevothyroxine Sodium Tablets, USP, 175 mcg in 90 ct bottles, Manufactured by Patheon Puerto Rico Inc., forJanuary 2, 2013
Questions about this recall
Was Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA. recalled?
Yes. FDA published recall D-103-2013 on January 2, 2013. Reported hazard: Subpotent; 9-month stability interval
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit